Exact Mass: 283.1545

Exact Mass Matches: 283.1545

Found 77 metabolites which its exact mass value is equals to given mass value 283.1545, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lysylhistidine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-5-yl)propanoic acid

C12H21N5O3 (283.1644)

Lysylhistidine is a dipeptide composed of lysine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Histidyllysine

(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C12H21N5O3 (283.1644)

Histidyllysine is a dipeptide composed of histidine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Cadralazine

N-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}ethoxycarbohydrazonic acid

C12H21N5O3 (283.1644)

C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DB - Hydrazinophthalazine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class. D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Histidinyl-Lysine

6-Amino-2-{[2-amino-1-hydroxy-3-(1H-imidazol-5-yl)propylidene]amino}hexanoate

C12H21N5O3 (283.1644)

2,3-Dimethoxy-6-methyl-5,6,7,8-tetrahydrodibenzo[c,e]azocine

2,3-Dimethoxy-6-methyl-5,6,7,8-tetrahydrodibenzo[c,e]azocine

C18H21NO2 (283.1572)

Coccuvinine

O-Methylcoccuvine

C18H21NO2 (283.1572)

Haplacutine A

Haplacutine A

C18H21NO2 (283.1572)

Haplacutine B

Haplacutine B

C18H21NO2 (283.1572)

Methylnaphthidate

Methylnaphthidate

C18H21NO2 (283.1572)

CCG-50531

CCG-50531

C12H21N5O3 (283.1644)

3-Methyl-1-[3-(2-hydroxy-3-methyl-3-butenyl)-1H-indol-5-yl]-2-buten-1-one

3-Methyl-1-[3-(2-hydroxy-3-methyl-3-butenyl)-1H-indol-5-yl]-2-buten-1-one

C18H21NO2 (283.1572)

(2E,4E)-N-(p-hydroxyphenylethyl)-2,4-decadien-9-ynamide|acmelline

(2E,4E)-N-(p-hydroxyphenylethyl)-2,4-decadien-9-ynamide|acmelline

C18H21NO2 (283.1572)

2,2-Dimethyl-3-[5-(3-methyl-2-butenoyl)-1H-indol-3-yl]propanal

2,2-Dimethyl-3-[5-(3-methyl-2-butenoyl)-1H-indol-3-yl]propanal

C18H21NO2 (283.1572)

3,5-Hexalobine D

3,5-Hexalobine D

C18H21NO2 (283.1572)

Pro Ala Pro

Pro Ala Pro

C13H21N3O4 (283.1532)

Ala Pro Pro

Ala Pro Pro

C13H21N3O4 (283.1532)

Pro Pro Ala

Pro Pro Ala

C13H21N3O4 (283.1532)

Lys His

Lys His

C12H21N5O3 (283.1644)

His Lys

His Lys

C12H21N5O3 (283.1644)

His-lys

2-(2,6-diaminohexanamido)-3-(1H-imidazol-5-yl)propanoic acid

C12H21N5O3 (283.1644)

A dipeptide formed from L-histidine and L-lysine residues.

Lys-his

6-amino-2-[2-amino-3-(1H-imidazol-5-yl)propanamido]hexanoic acid

C12H21N5O3 (283.1644)

Cadralazine

N-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}ethoxycarbohydrazonic acid

C12H21N5O3 (283.1644)

C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DB - Hydrazinophthalazine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

2-PHENYL-P-BUTYROPHENETIDIDE

2-PHENYL-P-BUTYROPHENETIDIDE

C18H21NO2 (283.1572)

N-(4-METHOXY-2-HYDROXYBENZYLIDENE)-4-N-BUTYLANILINE

N-(4-METHOXY-2-HYDROXYBENZYLIDENE)-4-N-BUTYLANILINE

C18H21NO2 (283.1572)

6,7-DIMETHOXY-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

6,7-DIMETHOXY-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE

C18H21NO2 (283.1572)

5-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

5-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

C14H25NO3Si (283.1604)

(3S,4S)-METHYL 1-METHYL-4-(NAPHTHALEN-2-YL)PIPERIDINE-3-CARBOXYLATE

(3S,4S)-METHYL 1-METHYL-4-(NAPHTHALEN-2-YL)PIPERIDINE-3-CARBOXYLATE

C18H21NO2 (283.1572)

Benzeneacetic acid, a-[[(phenylmethyl)amino]methyl]-,ethyl ester

Benzeneacetic acid, a-[[(phenylmethyl)amino]methyl]-,ethyl ester

C18H21NO2 (283.1572)

6-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

6-((tert-Butyldimethylsilyloxy)methyl)-2,3-dimethoxypyridine

C14H25NO3Si (283.1604)

Boc-L-(π-Me)-His-OMe

Boc-L-(π-Me)-His-OMe

C13H21N3O4 (283.1532)

Uracil,6-amino-5-(2-diethylaminoacetamido)-1,3-dimethyl- (6CI)

Uracil,6-amino-5-(2-diethylaminoacetamido)-1,3-dimethyl- (6CI)

C12H21N5O3 (283.1644)

2,4,6-TRIISOPROPYLBENZENESULFONAMIDE

2,4,6-TRIISOPROPYLBENZENESULFONAMIDE

C15H25NO2S (283.1606)

Beloxamide

N-phenylmethoxy-N-(3-phenylpropyl)acetamide

C18H21NO2 (283.1572)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

ethyl 2-(dibenzylamino)acetate

ethyl 2-(dibenzylamino)acetate

C18H21NO2 (283.1572)

9-(2,2-DIETHOXY-ETHYL)-9H-CARBAZOLE

9-(2,2-DIETHOXY-ETHYL)-9H-CARBAZOLE

C18H21NO2 (283.1572)

(1S,2S)-2-(Diphenylphosphino)cyclohexanamine

(1S,2S)-2-(Diphenylphosphino)cyclohexanamine

C18H22NP (283.149)

1-benzyl-3-(2-methoxyphenyl)pyrrolidin-3-ol

1-benzyl-3-(2-methoxyphenyl)pyrrolidin-3-ol

C18H21NO2 (283.1572)

N-(1-Methylazepan-4-yl)benzohydrazide

N-(1-Methylazepan-4-yl)benzohydrazide

C14H22ClN3O (283.1451)

COUMARIN 480 D DYE CONTENT 99

COUMARIN 480 D DYE CONTENT 99

C18H21NO2 (283.1572)

1-[2-AMINO-4-(PHENYLMETHOXY)-3-PROPYLPHENYL]-ETHANONE

1-[2-AMINO-4-(PHENYLMETHOXY)-3-PROPYLPHENYL]-ETHANONE

C18H21NO2 (283.1572)

Oxtriphylline

choline thieophyllinate

C12H21N5O3 (283.1644)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

(4R,4aR,7aS,12bS)-3,7-dimethyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol

(4R,4aR,7aS,12bS)-3,7-dimethyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol

C18H21NO2 (283.1572)

N-Benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

N-Benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

C18H21NO2 (283.1572)

6-Benzyloxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline

6-Benzyloxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline

C18H21NO2 (283.1572)

Nerispirdine

Nerispirdine

C17H18FN3 (283.1485)

C26170 - Protective Agent > C1509 - Neuroprotective Agent

Prolyl-prolyl-alanine

Prolyl-prolyl-alanine

C13H21N3O4 (283.1532)

1-(2-(3-Cyclohexenyl)ethyl)silatrane

1-(2-(3-Cyclohexenyl)ethyl)silatrane

C14H25NO3Si (283.1604)

1-(1-L-Alanyl-L-prolyl)-L-proline

1-(1-L-Alanyl-L-prolyl)-L-proline

C13H21N3O4 (283.1532)

N-methyl-N-phenylcarbamic acid (4-tert-butylphenyl) ester

N-methyl-N-phenylcarbamic acid (4-tert-butylphenyl) ester

C18H21NO2 (283.1572)

Diminazene(2+)

Diminazene(2+)

C14H17N7+2 (283.1545)

Pro-Ala-Pro

Pro-Ala-Pro

C13H21N3O4 (283.1532)

1-(2,5-Dimethoxyphenyl)-1-[(trimethylsilyl)oxy]propan-2-amine

1-(2,5-Dimethoxyphenyl)-1-[(trimethylsilyl)oxy]propan-2-amine

C14H25NO3Si (283.1604)

2-[(2S)-2-[(2R)-2-morpholinyl]-2-phenylethyl]phenol

2-[(2S)-2-[(2R)-2-morpholinyl]-2-phenylethyl]phenol

C18H21NO2 (283.1572)

lysylhistidine

lysylhistidine

C12H21N5O3 (283.1644)

Ala-Pro-Pro

Ala-Pro-Pro

C13H21N3O4 (283.1532)

Pro-Pro-Ala

Pro-Pro-Ala

C13H21N3O4 (283.1532)

4,5-dimethoxy-9-methyl-9-azatricyclo[10.4.0.0²,⁷]hexadeca-1(16),2(7),3,5,12,14-hexaene

4,5-dimethoxy-9-methyl-9-azatricyclo[10.4.0.0²,⁷]hexadeca-1(16),2(7),3,5,12,14-hexaene

C18H21NO2 (283.1572)

2-[(4e,6z)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(4e,6z)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)

2-[(3z,5z,7s)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

2-[(3z,5z,7s)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)

(9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline

(9bs,11r)-8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline

C18H21NO2 (283.1572)

2-[(3z,5e,7r)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

2-[(3z,5e,7r)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)

2-[(3s,4e,6e)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(3s,4e,6e)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)

n-[2-(4-hydroxyphenyl)ethyl]deca-2,4-dien-9-ynimidic acid

n-[2-(4-hydroxyphenyl)ethyl]deca-2,4-dien-9-ynimidic acid

C18H21NO2 (283.1572)

(1s,2r,4ar,5r)-8-isopropyl-2,5-dimethyl-5-(sulfanylideneamino)-1,3,4,4a,6,7-hexahydronaphthalene-1,2-diol

(1s,2r,4ar,5r)-8-isopropyl-2,5-dimethyl-5-(sulfanylideneamino)-1,3,4,4a,6,7-hexahydronaphthalene-1,2-diol

C15H25NO2S (283.1606)

8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline

8,11-dimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinoline

C18H21NO2 (283.1572)

1-{3-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-1h-indol-5-yl}-3-methylbut-2-en-1-one

1-{3-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-1h-indol-5-yl}-3-methylbut-2-en-1-one

C18H21NO2 (283.1572)

(1s,4r,4ar,7r)-1-isopropyl-4,7-dimethyl-4-(sulfanylideneamino)-3,4a,5,6-tetrahydro-2h-naphthalene-1,7-diol

(1s,4r,4ar,7r)-1-isopropyl-4,7-dimethyl-4-(sulfanylideneamino)-3,4a,5,6-tetrahydro-2h-naphthalene-1,7-diol

C15H25NO2S (283.1606)

2-(7-hydroxynona-3,5-dien-1-yl)-1h-quinolin-4-one

2-(7-hydroxynona-3,5-dien-1-yl)-1h-quinolin-4-one

C18H21NO2 (283.1572)

(1s,4s,4ar,7s)-1-isopropyl-4,7-dimethyl-4-(sulfanylideneamino)-3,4a,5,6-tetrahydro-2h-naphthalene-1,7-diol

(1s,4s,4ar,7s)-1-isopropyl-4,7-dimethyl-4-(sulfanylideneamino)-3,4a,5,6-tetrahydro-2h-naphthalene-1,7-diol

C15H25NO2S (283.1606)

2-[(4e,6e)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(4e,6e)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)

2,2-dimethyl-3-[5-(3-methylbut-2-enoyl)-1h-indol-3-yl]propanal

2,2-dimethyl-3-[5-(3-methylbut-2-enoyl)-1h-indol-3-yl]propanal

C18H21NO2 (283.1572)

1-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-5-yl}-3-methylbut-2-en-1-one

1-{3-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-5-yl}-3-methylbut-2-en-1-one

C18H21NO2 (283.1572)

(2e,4e)-n-[2-(4-hydroxyphenyl)ethyl]deca-2,4-dien-9-ynimidic acid

(2e,4e)-n-[2-(4-hydroxyphenyl)ethyl]deca-2,4-dien-9-ynimidic acid

C18H21NO2 (283.1572)

1-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-5-yl)-3-methylbut-2-en-1-one

1-(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-5-yl)-3-methylbut-2-en-1-one

C18H21NO2 (283.1572)

2-[(3s,4e,6z)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

2-[(3s,4e,6z)-3-hydroxynona-4,6-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)

1-[3-(2-hydroxy-3-methylbut-3-en-1-yl)-1h-indol-5-yl]-3-methylbut-2-en-1-one

1-[3-(2-hydroxy-3-methylbut-3-en-1-yl)-1h-indol-5-yl]-3-methylbut-2-en-1-one

C18H21NO2 (283.1572)

2-[(3z,5e)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

2-[(3z,5e)-7-hydroxynona-3,5-dien-1-yl]-1h-quinolin-4-one

C18H21NO2 (283.1572)